Clinical trial Recruiting at 1 site Interventional Ages 5 to 14

Greater auricular nerve block to reduce agitation after children's middle ear surgery

Official title: Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery: A PROSPECTIVE RANDOMIZED DOUBLE- BLINDED CLINICAL TRIAL

Run by Fayoum University · NCT07435675 · Data updated 2026-11-12

This trial will test whether an ultrasound-guided greater auricular nerve block can reduce agitation and pain when children wake up after microscopic middle ear surgery.

More Emergence Delirium trials

Quick facts

Study typeInterventional
Ages5 Years to 14 Years
SexAll
Enrollment74 (estimated)
SponsorFayoum University
Academic / other
Locations1 site (Al Fayyum, Faiyum Governorate)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedApril 1, 2026
Study endsApril 1, 2026
Registry record updatedFebruary 27, 2026
Trial IDNCT07435675 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5–14 years with ASA I–II scheduled for elective microscopic middle ear surgery who can be assessed with FLACC and PAED scores and whose parent or guardian provides consent.

Probably not a fit

Children with developmental or neurological disorders, significant hearing or communication impairment, allergy to amide local anesthetics, active infection at the block site, or those undergoing emergency/combined procedures are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial delivers an ultrasound-guided greater auricular nerve block (GANB) to children aged 5–14 undergoing elective microscopic middle ear surgery under general anesthesia. Postoperative emergence agitation (EA) occurrence and severity will be recorded using validated PAED and FLACC scores during the immediate 45-minute recovery period. Patients with neurological or communication impairments, local infection at the block site, or allergy to amide local anesthetics are excluded, and parental consent is required. The study compares postoperative EA and pain-related outcomes after targeted regional analgesia versus typical perioperative care to see if GANB lowers nociceptive-driven agitation.

Why it matters

Potential benefit: If successful, the nerve block could lower the frequency and severity of emergence agitation and reduce postoperative pain and related complications in children after middle ear surgery.

How similar studies have gone: Ultrasound-guided GAN blocks have been used successfully for postoperative analgesia in related adult and pediatric ear and parotid surgeries, but direct evidence specifically preventing pediatric emergence agitation after middle ear surgery is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 5 and 14 years (preschool to early school age group at highest risk for EA).
* ASA physical status I or II.
* Scheduled for elective microscopic middle ear surgery under general anesthesia (e.g., tympanoplasty, myringoplasty).
* Ability to comply with FLACC and PAED scoring during postoperative period.
* Informed consent obtained from a parent or legal guardian.

Exclusion Criteria:

* Known neurological, developmental, or psychiatric disorders (e.g., autism, ADHD, seizure disorder).
* Known hypersensitivity to amide local anesthetics (e.g., lidocaine, bupivacaine).
* Skin infection, hematoma, or trauma at or near the proposed block site.
* Non-elective (emergency) or combined surgeries.
* Inability to assess pain or agitation due to hearing loss, or communication impairment.
* Parental or legal guardian refusal to participate.

Where it's running

  • Fayoum University Hospital
    Al Fayyum, Faiyum Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.